Clinical Trial Update: A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder [Phase 4]

View source ↗

Summary

Phase 4 functional outcomes study comparing atomoxetine-hydrochloride to placebo in adults with Attention-Deficit/Hyperactivity Disorder has completed. Sponsor:…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Atomoxetine hydrochloride (Atomoxetine hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 4 | Status: COMPLETED